Lead Optimization Toxicology (Non-GLP)
Advance only the most promising compounds with our integrated approach to Lead Optimization toxicology.
Reduce timelines up to 40 days with our integrated Lead Optimization toxicology solution
Get the right study design working with a cross-functional team of experts
Anticipate and respond to challenges earlier — for better decision making
You already know you need toxicology studies in your early development process. But how early? The earlier, the better. Experience half the molecule attrition in later phases by initiating non-GLP toxicology studies alongside your in vivo work. Our shorter pre- and post-study times reduce your schedule by as much as 40 days, helping you identify your best candidates, sooner.
As you progress in your development journey, let us be your partner. We offer flexible design options, across multiple species, to help you determine which variables are the most crucial to isolate. By leveraging our integrated team of pharmacologists and pathologists, we help you find the right study solutions.
Early development is marked with unanticipated issues that can derail you in later phases. Through our integrated approach, we help you scientifically anticipate challenges and respond to them quickly. By integrating pharmacology, imaging and pathology into your toxicology study, you’re in a position to proactively resolve issues earlier in the journey — and more affordably.